USANA Health Sciences, Inc. USNA R2K

Consumer Defensive · Packaged Foods · United States

https://www.usana.com

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

Market & Price

Market Cap

$337.87M

Current Price

$18.30

High / Low (52W)

$35.43 / $16.90

Beta

0.77

Valuation

Stock P/E

36.60

Industry PE

18.88

Forward P/E

6.61

PEG Ratio

0.81

Book Value

$29.45

Price to Book

0.62

P/S

0.36

EV/EBITDA

2.95

Dividend Yield

Profitability & Returns

ROCE

6.90%

ROE

1.55%

ROA

4.13%

Profit Margin

0.96%

Op Margin

5.54%

EPS (Latest Qtr)

$0.41

EPS (TTM)

$0.50

Balance Sheet & Liquidity

Debt/Equity

2.35

Quick Ratio

1.47

Current Ratio

2.51

Debt

$14.00M

Total Assets

$742.91M

Current Assets

$288.40M

Working Capital

$159.84M

Ownership

Promoter Holding

40.88%

Chg in Prom Hold

FII / Inst Holding

56.59%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$240.36M

Total Revenue (TTM)

$925.94M

EBITDA

$81.56M

Free Cash Flow

$29.57M

Operating Cash Flow

$16.63M

Shares Outstanding

18.46M

Gross Margin

77.55%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

-2.51%

Profit 5Y

-46.27%

Revenue (YoY)

0.30%

Earnings (YoY)

-16.60%

PROS

Generates positive free cash flow.

CONS

Revenue declined at -2.5% CAGR over 5 years.
Earnings shrank at -46.3% CAGR over 5 years.
Trading 48.4% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	USNA USANA Health Sciences, Inc. R2K	18.30	36.60	$337.87M	-	6.90%	1.55%	-2.51%	-46.27%
2	WMT Walmart Inc. SPX	115.75	40.76	$922.64B	0.86%	18.21%	24.13%	5.27%	23.30%
3	COST Costco Wholesale Corporation NDXSPX	956.32	49.76	$424.27B	0.61%	27.44%	29.65%	6.64%	11.49%
4	KO The Coca-Cola Company SPX	79.01	24.85	$339.94B	2.68%	21.13%	43.37%	3.69%	11.16%
5	PG The Procter & Gamble Company SPX	143.56	21.02	$334.29B	2.97%	23.63%	31.11%	1.67%	2.71%
6	PM Philip Morris International Inc. SPX	177.38	24.98	$276.46B	3.31%	35.35%	-	8.57%	7.84%
7	PEP PepsiCo, Inc. NDXSPX	144.19	22.64	$197.10B	4.11%	15.23%	43.88%	2.83%	-2.57%
8	MO Altria Group, Inc. SPX	69.58	14.53	$116.19B	6.09%	40.85%	-	-0.89%	6.42%
9	MNST Monster Beverage Corporation NDXSPX	88.08	42.55	$86.14B	-	28.33%	26.65%	9.54%	16.94%

Quarterly Results

Figures in USD.

Metric	Oct 2015	Jan 2016	Apr 2016	Jul 2016	Oct 2016	Dec 2016	Apr 2017	Jul 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Apr 2021	Jul 2021	Oct 2021	Apr 2022	Jul 2022	Oct 2022	Apr 2023	Jul 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Apr 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	266.62M	258.99M	298.51M	307.98M	336.84M	274.35M	272.87M	264.47M	233.30M	248.36M	238.20M	213.37M	227.80M	212.87M	-	-	249.54M	235.85M	213.67M	226.20M	250.22M	250.22M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	52.45M	50.18M	48.81M	49.41M	59.44M	-
Gross Profit	192.24M	192.40M	197.53M	212.54M	209.24M	206.58M	212.67M	213.16M	214.63M	227.40M	242.62M	251.47M	244.89M	249.56M	227.09M	209.52M	212.78M	224.01M	220.56M	211.32M	242.16M	250.32M	279.82M	223.64M	221.48M	214.96M	186.74M	199.84M	194.88M	170.84M	184.73M	172.54M	-	-	197.09M	185.66M	164.85M	176.79M	190.78M	190.78M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	181.42M	168.95M	163.63M	159.54M	176.91M	-
Operating Income	37.97M	-	33.50M	37.45M	35.83M	-	32.89M	32.37M	31.36M	-	43.13M	51.14M	45.51M	-	35.00M	31.16M	35.46M	-	39.01M	39.59M	45.35M	44.20M	53.72M	40.77M	33.07M	29.37M	22.63M	26.84M	24.40M	17.61M	24.67M	17.84M	-	-	15.67M	16.72M	1.22M	17.25M	13.87M	13.87M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	27.39M	28.68M	11.41M	14.59M	25.49M	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	411.00K	259.00K	49.00K	123.00K	240.00K	-
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16.74M	18.82M	1.79M	4.18M	15.46M	-
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7.45M	8.37M	8.46M	5.77M	8.51M	-
Net Income	25.61M	23.97M	22.30M	25.76M	30.10M	21.88M	21.36M	23.26M	23.77M	-5.85M	28.95M	33.91M	31.04M	32.33M	24.17M	21.38M	24.22M	30.75M	26.55M	27.98M	30.51M	30.62M	38.23M	27.33M	22.47M	19.16M	14.93M	18.38M	17.29M	11.35M	16.54M	10.43M	-	-	9.29M	9.65M	-6.52M	-1.77M	6.96M	7.51M
Diluted EPS	0.96	0.92	0.89	1.03	1.20	0.87	0.86	0.93	0.97	-0.24	1.19	1.36	1.24	1.32	1.01	0.91	1.09	1.41	1.23	1.32	1.44	1.45	1.87	1.36	1.15	1.00	0.78	0.95	0.89	0.59	0.86	0.54	-	-	0.49	0.52	-0.36	-0.10	0.41	0.41

Profit & Loss (Annual)

Figures in USD.

Metric	Jan 2010	Jan 2011	Dec 2011	Dec 2012	Dec 2013	Jan 2015	Jan 2016	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Jan 2021	Dec 2021	Jan 2022	Dec 2022	Dec 2023	Dec 2024	Dec 2025	Jan 2026
Revenue	-	-	-	-	-	-	-	-	-	1.19B	1.06B	1.13B	-	1.19B	998.60M	921.01M	854.50M	925.26M	925.26M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	193.89M	176.69M	161.21M	200.85M	-
Gross Profit	347.14M	422.16M	480.25M	532.92M	590.74M	649.68M	758.82M	825.89M	867.86M	988.54M	873.40M	925.53M	-	968.57M	804.71M	744.32M	693.29M	724.40M	724.40M
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	697.10M	651.25M	626.97M	673.54M	-
Operating Income	50.79M	68.22M	77.26M	98.18M	116.71M	116.10M	141.66M	138.62M	132.50M	188.35M	146.19M	176.49M	-	170.19M	107.61M	93.07M	66.32M	50.86M	37.43M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	130.22M	123.11M	98.86M	82.07M	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	192.00K	262.00K	281.00K	842.00K	-
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	108.62M	102.45M	76.35M	41.53M	-
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	39.27M	38.66M	34.29M	30.05M	-
Net Income	33.56M	45.65M	50.75M	66.43M	79.02M	76.64M	94.67M	100.04M	62.53M	126.22M	100.53M	124.66M	-	116.50M	69.35M	63.79M	42.03M	10.76M	10.76M
Diluted EPS	2.17	2.86	3.26	4.45	5.56	2.80	3.59	3.99	2.53	5.12	4.41	5.86	-	5.73	3.59	3.30	2.19	0.58	0.58
R&D Expense	-	3.84M	4.07M	4.66M	5.08M	5.13M	6.42M	8.84M	8.95M	10.24M	10.26M	10.63M	-	11.11M	11.56M	11.45M	11.57M	-	10.69M

Compounded Sales Growth

5 Years:	-2.51%
1 Year:	0.30%

Compounded Profit Growth

5 Years:	-46.27%
1 Year:	-16.60%

Stock Price Performance

1 Year:	-38.73%
6 Months:	-7.58%
3 Months:	-14.96%
1 Month:	-2.24%

Balance Sheet (Annual)

Figures in USD.

Metric	Jan 2009	Jan 2010	Jan 2011	Dec 2011	Dec 2012	Dec 2013	Jan 2015	Jan 2016	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Jan 2021	Jan 2022	Dec 2022	Dec 2023	Dec 2024	Dec 2025	Jan 2026
Total Assets	-	-	216.64M	244.50M	267.36M	368.47M	350.58M	423.24M	470.64M	519.27M	554.46M	516.93M	640.89M	577.74M	596.55M	632.76M	748.19M	742.91M	742.91M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	384.38M	417.75M	279.19M	288.40M	-
Cash & Equivalents	13.28M	13.66M	50.35M	50.35M	70.84M	137.34M	111.13M	143.21M	175.77M	247.13M	214.33M	234.83M	311.92M	239.83M	288.42M	330.42M	181.77M	158.38M	158.38M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	67.09M	61.45M	69.73M	102.61M	-
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7.21M	7.20M	8.22M	9.11M	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	162.08M	135.56M	161.86M	156.64M	156.64M
Current Liabilities	-	-	59.03M	59.70M	70.84M	95.87M	108.70M	131.41M	138.49M	141.18M	148.69M	136.10M	168.07M	160.79M	143.83M	118.84M	139.62M	128.56M	128.56M
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6.89M	8.06M	29.01M	19.65M	-
Total Equity	31.84M	74.37M	146.80M	173.91M	185.57M	260.52M	230.16M	280.85M	325.29M	363.21M	391.15M	351.71M	441.65M	395.12M	434.47M	497.20M	532.11M	533.10M	533.10M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	19.21M	19.13M	19.06M	18.28M	-

Cash Flows (Annual)

Figures in USD.

Metric	Jan 2010	Jan 2011	Dec 2011	Dec 2012	Dec 2013	Jan 2015	Jan 2016	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Jan 2021	Dec 2021	Jan 2022	Dec 2022	Dec 2023	Dec 2024	Dec 2025	Jan 2026
Operating Cash Flow	32.47M	66.11M	70.11M	92.81M	98.89M	105.19M	111.47M	136.89M	123.77M	152.12M	126.73M	160.40M	-	121.23M	103.90M	70.64M	60.99M	22.35M	22.35M
Investing Cash Flow	-3.20M	-46.85M	-10.61M	-8.28M	-21.59M	-16.27M	-25.12M	-31.88M	-12.90M	-69.00M	47.49M	-33.96M	-	-14.19M	-12.37M	-11.97M	-213.09M	-10.12M	-10.12M
Financing Cash Flow	-29.50M	-9.58M	-33.37M	-64.54M	-10.16M	-113.02M	-49.16M	-64.86M	-50.32M	-105.28M	-152.05M	-59.44M	-	-181.41M	-30.09M	-14.24M	9.55M	-40.60M	-40.60M
Capital Expenditure	-4.13M	-4.19M	-10.64M	-8.43M	-8.05M	-20.42M	-23.73M	-32.70M	-13.22M	-11.43M	-16.57M	-15.09M	-	-12.76M	-10.40M	-14.49M	-10.07M	-13.82M	-13.82M
Free Cash Flow	28.34M	61.92M	59.47M	84.37M	90.84M	84.76M	87.74M	104.19M	110.55M	140.69M	110.16M	145.31M	-	108.46M	93.50M	56.15M	50.92M	8.53M	8.53M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-	61.44M	44.43M	-142.54M	-28.38M	-
Share Buybacks	1.65M	17.03M	33.46M	68.29M	18.09M	138.82M	61.18M	64.61M	50.00M	105.38M	150.00M	57.03M	-	177.84M	25.38M	11.60M	9.44M	-	27.51M

Ratios (Annual)

Figures in %.

Metric	Jan 2010	Jan 2011	Dec 2011	Dec 2012	Dec 2013	Jan 2015	Jan 2016	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Jan 2021	Dec 2021	Jan 2022	Dec 2022	Dec 2023	Dec 2024	Dec 2025	Jan 2026
Gross Margin %	-	-	-	-	-	-	-	-	-	83.1%	82.3%	81.6%	-	81.6%	80.6%	80.8%	81.1%	78.3%	78.3%
Operating Margin %	-	-	-	-	-	-	-	-	-	15.8%	13.8%	15.6%	-	14.3%	10.8%	10.1%	7.8%	5.5%	4.0%
Net Margin %	-	-	-	-	-	-	-	-	-	10.6%	9.5%	11.0%	-	9.8%	6.9%	6.9%	4.9%	1.2%	1.2%
ROE %	45.1%	31.1%	29.2%	35.8%	30.3%	33.3%	33.7%	30.8%	17.2%	32.3%	28.6%	28.2%	-	29.5%	16.0%	12.8%	7.9%	2.0%	2.0%
ROCE %	-	43.3%	41.8%	50.0%	42.8%	48.0%	48.5%	41.7%	35.0%	46.4%	38.4%	37.3%	-	40.8%	23.8%	18.1%	10.9%	8.3%	6.1%

Shareholding Pattern

Insiders

40.88%

Institutions

56.59%

Public Float

95.72%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	6.45%	1.19M	$21.78M
2	Pzena Investment Management LLC	6.01%	1.11M	$20.29M
3	Renaissance Technologies, LLC	5.51%	1.02M	$18.62M
4	Dimensional Fund Advisors LP	4.52%	834.22K	$15.27M
5	Nantahala Capital Management, LLC	4.39%	810.07K	$14.82M
6	Vanguard Capital Management LLC	2.59%	479.04K	$8.77M
7	Vanguard Portfolio Management LLC	1.83%	338.27K	$6.19M
8	Charles Schwab Investment Management, Inc.	1.80%	333.11K	$6.10M
9	AQR Capital Management, LLC	1.61%	296.42K	$5.42M
10	Geode Capital Management, LLC	1.43%	264.43K	$4.84M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for USNA

No recent headlines available.

USNA · Consumer Defensive